2022Ä꣬ÑۿƾµäÔÓÖ¾¡¶Cornea¡·»ØÊ×·¢Ã÷£¬±»Òý´ÎÊý×î¶àµÄʵÑéÐÔÑо¿ÊÇ1995ÄêÉúÎïÑòĤ£¨Ì¥ÅÌÄÚ°ü¹üÑòË®µÄ±¡Ä¤£©ÓÃÓÚÑÛ±íÖØÐÞµÄÂÛÎÄ¡£³ýÑÛ¿ÆÍ⣬ÑòĤ¿ÉÓ¦ÓÃÓÚÍâÉËÐÞ¸´¡¢¹Ç¿ÆµÈÁìÓò£¬¿°³ÆÍò½ðÓÍ¡£È»¶ø£¬ÉúÎïÑòĤÔÚÁÙÅèºóͨ³£±»¿´³ÉÒ½ÁÆ·ÏÎïÏú»Ù¡£ÕâÑùÒ»¸öÒ½ÁÆ·ÏÎÊÇÔõÑùÄæÏ®µÇÉÏÊÖÊǫ̃£¬³ÉΪ×îÊÜÖõÄ¿µÄÔÙÉúÖÊÁÏ£¿
´Ó»ùµ×Ĥ¡¢Ó²ÄÔĤµ½Ò»Ð©Ö÷ÒªÆ÷¹Ù£¬Ä¤Æձ鱣´æÓÚÈËÌå¡£×ÔȻĤÖÊÁϾ߱¸¸ß¶ÈµÄÉúÎïÏàÈÝÐԺʹó×Ú»îÐÔÒò×Ó£¬³ýÁ˸ôÀë·À»¤×÷Ó㬻¹¿ÉÒÔ×÷ΪÔÙÉúÖÊÁÏ¡£
ÒÑÍùÒ»°ÙÄêÖУ¬ÈËÀàʵÑé°ÑÖÖÖÖÉúÎïĤÓÃ×÷ÐÞ¸´ÔÙÉú£¬´ÓƤ·ô¡¢½ÇĤµ½¿ÚÇ»£¬´ÓÈËÌåµ½ÖíС³¦ð¤Ä¤¡¢Ð¡Å£ÕæƤÉõÖÁ¼¦µ°Ä¤¡£ÖîÈçÖíϲãð¤Ä¤µÈ×ÔȻĤÒѱ»ÓÃ×÷ðÞ²¹Æ¬¡¢Ó²ÄÔĤ¡¢¿ÚǻĤµÈ£¬ÔÐÓýÁËÕýº£ÉúÎï¡¢¹Úê»ÉúÎïµÈÉÏÊй«Ë¾¡£
ÔÚ×ÔȻĤÖÊÁÏÖУ¬ÉúÎïÑòĤÊÇΨһ¸ôÀëÁ½Ð¡ÎÒ˽¼ÒµÄÈËÌå×éÖ¯¡£ÑòĤÒò°ü¹üÑòË®¶øµÃÃû£¬ÊÇÌ¥ÅÌ×îÄÚ²¿µÄ͸Ã÷±¡Ä¤£¬ÓëÌ¥¶ùÖ±½Ó½Ó´¥¡£ÑòĤ´Óϸ°û×ÌÑø²ãÑÝ»¯¶øÀ´£¬¸ôÀëÁËÔи¾ÓëÌ¥¶ù£¬²¢ÇÒÖ§³ÖÌ¥¶ùµÄ·¢Óý£¬¾ß±¸×ÔÈ»µÄ¸ßÉúÎïÏàÈÝÐÔÓë¶à»îÐÔÒò×Ó¡£
ÑòĤµÄÔÙÉúҽѧDZÁ¦ÔÚ20ÊÀ¼Í³õ¼´±»¾ò¿Í¡£1910Ä꣬Davis µÚÒ»´Î±¨µÀÁËÓòú¸¾ÑòĤ×÷ΪÍâ¿ÆƤ·ôÒÆÖ²µÄÖÊÁÏ£»ËæºóÑòĤÔÚƤ·ôÉÕÉ˺ÍƤ·ôÀ£ÑñµÄÖÎÁÆ¡¢È˹¤ÒõµÀÖÊÁÏ¡¢½ÇĤÖØÐÞµÄÓ¦Óþù»ñµÃÀֳɡ£½üÎåÄêµÄÁÙ´²ÊÔÑéÖУ¬ÑòĤ˳Ӧ֢¼¯ÖÐÔÚÍâÉËÐÞ¸´¡¢¹Ç¿Æ¼°ÑÛ¿ÆÁìÓò£¬ÒÑÓÐÏà¹Ø²úÆ·ÉÏÊУ»ÔÚÃÚÄò¿Æ¡¢¿ÚÇ»ºÍÖ×ÁöÁìÓòÉÐÊôת»¯½×¶Î¡£Áè¼Ý 50%µÄÁÙ´²Ñо¿ÔÚÃÀ¹úÍê³É£¬ÒÑÓлñÅú²úÆ·¡£½ôËæØʺóµÄÖйú¡¢°£¼°¡¢Ó¡¶È¡¢ÒÁÀʺ͵¹úÒ²½«Óиü¶à²úÆ·»ñÅú¡£
1.1 ÑÛ¿ÆÓ¦Ó㺴µ¾¡»Æɳʼµ½½ð
1940 Ä꣬De Roth Ê״ν«ÑòĤӦÓÃÓÚÑÛ²¿£¬ÐÞ¸´½áĤȱË𡣽ǽáĤÉÏƤȱË𱬷¢ÓÚÉÕÉË¡¢À£Ññ¡¢Òí×´æÀÈâÊõºó¡¢±í²ã½ÇĤÇü¹âÊõºóµÈ¡£¹Å°åµÄÑÛ±íÖØÐÞ½ÓÄÉļ¾èȪԴµÄ½ÇĤºÍ×ÔÌå½áĤÒÆÖ²£¬±£´æ½ÇĤ¹©Ìå½ôȱºÍ×ÔÌå½áĤÔì³ÉÒ½Ô´ÐÔËðÉ˵ÈÎÊÌâ¡£
ÒÀ¾Ý¾µäµÄ¡°XYZ¼Ù˵¡±£¬ÑÛÇòĤµÄÍêÕûÒÀÀµÓÚÔÙÉúÆøÖÆ£¬´ó×ÚÉÏƤϸ°ûµÄËðʧÓë¿ìËÙÔÙÉú¸æ¿¢Æ½ºâ¡£µ±·ºÆð×é֯ȱËð¡¢½ÇĤԵ¸Éϸ°ûÒ쳣ʱ£¬ÑÛÇòµÄÔÙÉúÆøÖÆÄÑÒÔΪ¼Ì¡£Òò´Ë£¬ÑÛÇòĤµÄÐÞ¸´¶ÔÖ¤ÁϵÄÒªÇ󼫸ߡ£
De RothʵÑéÁËÖÖÖÖ×ÔȻĤÖÊÁϺ󣬷¢Ã÷ÑòĤ¿ÉÄÜÊÇΨһµÄÀíÏëÔÙÉúÖÊÁÏ£º£¨1£© Ƥ·ô£ºÓ²ÖÊ¡¢¾ßÓÐÑÕÉ«£»£¨2£©¿ÚÇ»ð¤Ä¤£ººìÉ«¡¢³ß´çÓÐÏÞ£»£¨3£©ÒõµÀð¤Ä¤£ºÑéÖ¤ÓÐÓ㬵«¿ÉÄÜ»áÒÆÖ²ºóËõ¶Ì£»£¨4£©°üƤ£ºÐ§¹ûºÃ£¬µ«»¼Õ߾ܾø´ÓÔÆÔÆųÈõµÄµØ·½ÒÆÖ²¡£
¶øÑòĤ¾ß±¸±¡¡¢Æ½»¬¡¢Í¸Ã÷¡¢ÎÞѪ¹ÜµÈÌص㣬Óë½áĤ×îΪÏàËÆ£¬²¢¿ÉÒÔ´ó×Ú»ñµÃ¡£De Roth½«ÑòĤӦÓÃÔÚÁË8̨ÊÖÊõÖУ¬Ð§¹ûÏÔʾÔÚÑòĤ±»ÎüÊÕºó£¬ÔȱËðÇøÓòÏñÕý³£½ÇĤһÑù¡£
ÔÚ´ËÖ®ºó£¬×îÏÈÁËÑòĤÔÚÑÛ¿ÆÓ¦ÓõÄÆÕ±éʵÑé¡£µ«ÓÉÓÚÊìϤ²»Ç壬´ó×ÚÑо¿»ìÓÃÁË̥Ĥ¡¢ÈÞëĤ£¨ÑòĤÃâÒßÔÐÔµÄÖ÷ҪȪԴ£©¡¢ÑòĤ£¬µ¼ÖÂÑо¿Ð§¹ûÁ¼Ý¬²»Æ룬ÑòĤ²¢Ã»Óдó¹æÄ£ÆÌ¿ªÊ¹Óá£Ö±µ½1995Ä꣬KimºÍTsengÀֳɵØʹÓÃÑòĤ¶Ô½ÇĤ¼°½ÇĤԵ¸Éϸ°ûȱËðµÄÍÃ×Ó¾ÙÐÐÒÆÖ²£¬Ïà¹ØЧ¹û½ÒÏþÓÚÑۿƾµäÔÓÖ¾¡¶Cornea¡·£¬ÔÙ¶ÈÒý·¢Èȳ±¡£
ÔÚ2022Ä꡶Cornea¡·»ØÊ×ÖÐÌá¼°£¬KimºÍTsengµÄÕâƪÉúÎïÑòĤÎÄÕ³ÉΪÁ˱»Òý´ÎÊý×î¶àµÄʵÑéÐÔÑо¿¡¢ÒÔ¼°±»Òý´ÎÊýµÚ¶þ¶àµÄ½ÇĤÎÄÏס£
ÁÙ´²Êµ¼ùÖУ¬ÉúÎïÑòĤ¿ÉÓÃÓÚÒí×´æÀÈâ¡¢½ÇĤÉÏƤȱËð¡¢Çà¹âÑÛµÈÊÖÊõ¡£¿ÉÒÔ˵¹Å°åµÄÒÆÖ²ÊÖÊõ¾ù¿ÉÓÃÑòĤÌæ»»»òÁªÓá£
ÌØÊâÊÇÒí×´æÀÈ⣬º£ÄÚÄêÊÖÊõÁ¿¸ß´ï150Íǫ̀£¬Í¨³£Ðд¿´âÇгýÊõ£¬Ô¼Ò»°ë»¼Õ߻Ḵ·¢£»¶øÍŽáÑòĤÒÆÖ²Êõ+Ë¿ÁÑùËØCºó£¬¸´·¢ÂʿɽµÖÁ5.8%¡£²¿·ÖÑо¿ÏÔʾ¸´·¢ÂÊÂÔ¸ßÓÚ×ÔÌå½áĤÒÆÖ²Êõ£¬µ«µ±È±ËðÃæ»ý½Ï´óʱ£¬ÑòĤÒÆÖ²×èÖ¹ÁË´óÃæ»ýÈ¡ÓýáĤÔì³ÉµÄÒ½Ô´ÐÔËðÉË£¬ïÔÌñ£ºÛ»¯¡£²¢ÇÒæÀÈâÇгýÊõºó£¬ÍŽá×ÔÌå½áĤÒÆÖ²¡¢ÑòĤÒÆÖ²£¬¿É½µµÍÊõºóÑ×Ö¢¼¸ÂÊ£¬½øÒ»²½½µµÍ¸´·¢ÂÊ¡£
ÉúÎïÑòĤҲ¿ÉÓÃÓÚÇà¹âÑÛÂ˹ýÊõºó£¬ÓÃÀ´ÒÖÖÆñ£ºÛÐγɡ£È«ÇòÇà¹âÑÛ»¼²¡ÈËȺÖУ¬Ô¼ËÄ·ÖÖ®Ò»µÄ»¼ÕßÀ´×ÔÖйú£¬2020Äê´ï2100Íò£¬ÖÂîÕßÊýµÖ´ï567Íò¡£Çà¹âÑÛ³£ÓÃÊõʽΪͨÀýСÁºÇгýÊõ£¬ÀÖ³ÉÂʽöΪ11%~52%¡£½áĤÏÂÂ˹ýÅÝñ£ºÛ»¯Êǵ¼ÖÂÇà¹âÂ˹ýÊÖÊõʧ°ÜµÄÖ÷ÒªÔµ¹ÊÔÓÉ£¬»¼ÕßÍùÍùÐèÒªÖظ´ÊÖÊõ¡£ÍŽáÑòĤÒÆÖ²Êõ£¬½«ÑòĤÖÃÓÚ½áĤ±ßÑØ¡¢¹®Ä¤°êÏ£¬¿ÉʹÓÃÑòĤµÄ¿¹ÏËά»¯ÌØÕ÷¸ÄÉÆÔ¤ºó¡£
1.2 ÆäËûѧ¿Æ£ºÖ±¹ÒÔÆ·«¼Ã²×º£
ÍâÉËÐÞ¸´ºÍ¹Ç¿ÆÊÇÉúÎïÑòĤÂÊÏÈÉÌÒµ»¯µÄÁìÓò¡£´óÃæ»ýÉî¶ÈÉÕÉË¡¢ÄÑÓúÐÔÀ£ÑñÈçÌÇÄò²¡×ãÀ£ÑñµÈÐÞ¸´ÄÑÌ⣬¾ù¿ÉÓ¦ÓÃÉúÎïÑòĤ£¬´Ùѧϰ¸´£¬ÒÖÖÆñ£ºÛ±¬·¢¡£
ÉúÎïÑòĤÔÚÌåÄÚÍâͬÑù±»Ö¤Êµ¾ßÓÐÐÞ¸´¹ÇȱËð¡¢Èí¹ÇËðÉ˺ͼ¡ëìËðÉ˵ÄÄÜÁ¦¡£¼¡ëìËðÉËÐÞ¸´ÖУ¬ËðÉ˲¿Î»·ìºÏºó°ü¹üÑòĤ£¬¿ÉÏÔןÄÉƾֲ¿ð¤Á¬£¬Ôö½ø¼¡ë콺ÔÏËάºÏ³É£¬Ëõ¶ÌÐÞ¸´Ê±¼ä£¬¼¡ëì³ÐÔØÁ¦ÏÔ×ÅÓÅÓÚͨÀý·ìºÏ¡£
¹ÄĤ´©¿×ÖУ¬¶úÄÚ¾µÏßÏÂÉúÎïÑòĤÒÆÖ²ÐйÄĤ´©¿×ÐÞ²¹Êõ£¬×èÖ¹×ÔÌåÈ¡²Ä´´ÉËÓëñ£ºÛ£¬¾ßÓÐÊÖÊõ¶Ì£¬³öѪÉÙµÈÓŵ㡣ÆäËûÁìÓòÈç±ÇÀá¹ÜÖØÐÞ¡¢Éñ¾ÎǺÏÐÞ¸´¡¢×Ó¹¬ÄÚĤÐÞ¸´µÈ¾ù¿ÉÓ¦ÓÃÑòĤ¡£
ÑòĤÊÇÈËÌå×îºñµÄĤ֮һ£¬ÊÇÒ»ÖÖÎÞÉñ¾¡¢¼¡ÈâºÍÁܰ͹ܵİë͸Ã÷Ĥ״×éÖ¯£¬Ö÷ÒªÓÉÑòĤÉÏƤϸ°û¡¢ÑòĤ¼ä³äÖʸÉϸ°ûºÍ³ÉÏËάϸ°û×é³É¡£ÑòĤ×ÔÍâÏòÄÚ£¬¿É·ÖΪÉÏƤϸ°û²ã¡¢»ùµ×Ĥ¡¢ÖÂÃܲ㡢ÏËάϸ°û²ã¼°º£Ãà²ãÎå¸ö²¿·Ö¡£
͸Ã÷¡¢ÎÞѪ¹ÜʹÑòĤÊʺÏÒÆÖ²£»¸»ºñµÄ½ºÔÏËά°ü¹ÜÁË¿¹ÀÁ¦£»»ùµ×²ã¸»ºñµÄ°ëÇÅÁ£ÒÔ¼°ÖØ´óµÄ½ºÔÍøÂçʹÉÏƤϸ°ûÒ×ÓÚÉú³¤¼°Õ³¸½£»ÑòĤÍâòµÄÃÔ·¹ÜµÀϵͳʹÆäÒ×ÓÚ¾ÙÐÐÎïÖʽ»Á÷£»×÷ΪͬÖÖÒìÌåÖÊÁÏ£¬²»±í´ïHLA-A,B,C£¬DR£¬¿¹ÔÐÔ¼«µÍ£¬¿É×èÖ¹ÃâÒßÇãÔþ·´Ó¦¡£
ÓÉÓÚÆæÒìµÄ×é֯ѧ½á¹¹¡¢·±¶àµÄ»îÐÔÒò×Ó£¬ÑòĤÄܹ»Ôö½øÉÏƤÐγɣ¬ÒÖÖÆÑ×Ö¢ºÍÐÂÉúѪ¹Ü¡¢ÒÖÖÆÏËά»¯¡£
×éÖ¯¹¤³ÌÊÖÒÕ°üÀ¨3¸öÒªËØ£¬¼´Éú³¤Òò×Ó¡¢ÖÖ×Óϸ°ûºÍÖ§¼ÜÖÊÁÏ¡£ÔÚϸ°û²ãÃ棬ÑòĤ¸»º¬ÑòĤÉÏƤ¸Éϸ°û£¨AEC£©ºÍÑòĤ¼ä³äÖʸÉϸ°û£¨AMSCs£©£¬ÕâЩϸ°û¾ßÓи߶ȿÉËÜÐÔ£¬ÏÔʾ¶àÏò·Ö½âDZÄÜ£¬²¢ÇÒÔÚÒÆÖ²ºóûÓÐÖÂÁöΣº¦¡£¼ÓÖ®¸»ºñµÄϸ°ûÒò×Ó£¬ÆæÒìµÄ×éÖ¯½á¹¹£¬ÑòĤÊÇÀíÏëµÄÔÙÉúÖÊÁÏ¡£
3.1 ÉÌÆ·ÑòĤ£º×·ÇóÌù½üÐÂÏÊ״̬µÄ´¦Öóͷ£·½·¨
ÉúÎïÑòĤȡ×Ô¾èÔùµÄÌ¥ÅÌ£¬Æʹ¬²úºó½«ÑòĤ´ÓÈÞëĤÉÏÊèÉ¢£¬¾Ï´åª¡¢Ãð¾ú£¬¿ÉµÃÐÂÏÊÑòĤ¡£ÐÂÏÊ£¨»òÀä²Ø£©ÑòĤÄܹ»×îºéÁ÷ƽ±£´æÖÖÖÖ×ÔÈ»½ºÔ¼°»îÐÔÒò×ÓÒòËØ£¬Òò´ËÁÙ´²Ê¹ÓÃЧ¹û½ÏºÃ¡£
ÔºÄÚ×ÔÖÆÑòĤÓÉÓÚÃð»î·½·¨¼òÆÓ£¬ÇÒȱÉÙÖʼ첽·¥£¬ÁÙ´²Ê¹Óñ£´æѬȾΣº¦¡£ÁÙ´²Ø½ÐèÌù½üÐÂÏÊÑòĤ¡¢¸üÇå¾²¡¢±ê×¼»¯µÄÑòĤÉÌÆ·£¬ÌôÕ½Ö÷ÒªÀ´×ÔÓÚÈ·±£Ãð¾ú¡¢Ìù½üÐÂÏÊ״̬µÄ´¦Öóͷ£ºÍÖü´æÊÖÒÕ¡£
ÏÖÔÚÑòĤµÄÖü´æÒªÁìÖ÷Òª°üÀ¨¶³¸ÉºÍÀ䶳ÉúÑÄ¡£¶³¸ÉÊǽ«ÑòĤÔÚÔÚ -50ÖÁ-80¡ãCÏ¿ìËÙÀ䶳£¬È»ºóʹÓÃÀ䶳¸ÉÔï»úÔÚ¸ßÕæ¿ÕϸÉÔͨ¹ýÉý»ªÌáÈ¡×éÖ¯Öб£´æµÄË®£¬ÒÔ½«Ë®º¬Á¿½µµÍÖÁ5-10%¡£À䶳ÉúÑÄÊǽ«ÑòĤÉúÑÄÔÚDMEM©U¸ÊÓÍ°´1£º1±ÈÀýÅäÖƵÄÉúÑÄÒºÖУ¬²¢ÓÚ-80¡æ±ùÏäÖж³´æ£¬ÓÐÓÃÆÚΪ1ÖÁ2Äê¡£
¶³¸ÉÑòĤËäÈ»¾ßÓÐÊÒÎÂÖü´æºÍÔËÊäµÄÓÅÊÆ£¬ÓÉÓÚ¶³¸É¡¢ÍÑϸ°ûµÈ¹¤ÒÕÓ°Ï죬ÁÙ´²Ð§¹ûÓëÐÂÏÊÑòĤ²îÖ®ÉõÔ¶¡£²»µ«ËðʧÁË´ó×ÚÓÐÓÃÒòËØ£¬»¹ÈÝÒ×Ôì³ÉÂÑ°×ÖʱäÐÔ¡¢ÑòĤÖÖÖÖÀí»¯ÐÔÄܽµµÍ£¬Ö±½Óµ¼ÖÂÑòĤÔÚÊÖÊõÖÐÒ×˺ÁÑ£¬ÐèÒªÖظ´Ìæ»»£¬ÑÓÉìÊÖÊõʱ¼ä£»ÊõºóÑ×Ö¢·´Ó¦Ç¿ÁÒ£¬ÑòĤÈÝÒ׿ìËÙ½µ½â¡¢ÍÑÂä¡£Òò´Ë¶³¸ÉÑòĤÖ÷ÒªÓ¦ÓÃÓÚ¶Ô»îÐÔÒò×Ó¡¢×éÖ¯½á¹¹ÒªÇó½ÏµÍµÄÉË¿ÚÕչ˻¤Ê¿¡¢¹Ç¿ÆÁìÓò£¬ÉÌÆ·»¯ÑòĤ¹«Ë¾ÒÔMIMEDX£¨NASDAQ:MDXG)£©Îª´ú±í£¬º£ÄÚÒÔÈð¼ÃÉúÎïΪÖ÷¡£
À䶳ÉúÑĵÄÉÌÆ·ÑòĤÒÔTissueTechΪ´ú±í£¬µ«ÓÉÓÚºã¾ÃÉîµÍÎÂÉúÑı¾Ç®½Ï¸ß£¬²¢ÇÒÆ乤ÒÕδ¶ÔÑòĤ¾ÙÐÐÃð¾úºÍ²¡¶¾Ãð»î´¦Öóͷ££¬ÎÞ·¨´ó¹æÄ£Íƹ㡣ÑÛ¿ÆÁìÓò£¬ÃÀ¹úÈÔÒÔ×ÔÖÆÑòĤΪÖ÷¡£
3.2 ÁÙ´²Êг¡£ºØ½ÐèÁ¢Òì²úÆ·ÆƾÖ
¾ÝApollo Research Reportsµ÷ÑУ¬2022ÄêÈ«ÇòÉúÎïÑòĤÊг¡¹æÄ£µÖ´ï32.6ÒÚÃÀÔª¡£Ö÷ÒªÓ¦ÓÃÓÚÉË¿ÚÐÞ¸´¡¢¹Ç¿Æ¼°ÑÛ¿Æ¡£Î´À´ÑòĤ×÷Ϊ¸ßÐÔÄÜÔÙÉúҽѧÖÊÁÏ¿ÉÍØÕ¹ÖÁÊýÊ®¸öÁìÓò£¬»Ý¼°ÒÚÍò»¼Õß¡£
ÊÂʵÉÏ£¬Ö»¹ÜÁÙ´²Ö¤¾Ý¸»×㣬ÊÜÏÞÓÚ¶³¸ÉÑòĤµÄÁÓÊÆ£¬ÑòĤÊÖÊõÉø͸ÂÊÈÔÈ»¼«µÍ¡£²¢ÇÒ£¬ÏÖÓÐÑòĤÊÖÊõÈÔ´ó×ÚʹÓÃÔºÄÚ×ÔÐаþÖƵÄÐÂÏÊÑòĤ»ò¸ÊÓÍÉúÑÄÑòĤ¡£
ÔÚÃÀ¹ú£¬×Ô 2000 ÄêÒÔÀ´£¬¾Ý¡¶¹«¹²ÎÀÉúЧÀÍ·¨¡·µÚ361ÌõÌõ¿î£¬Õë¶Ô×ÔÌåȪԴ¡¢×îС»¯´¦Öóͷ£ºÍͬԴʹÓõÄ×é֯ϸ°û²úÆ·£¨HCT / P£©£¬ÎÞÐèÉÏÊÐÉóÅú£¬½öÐ豸°¸¡£·ÇͬԴʹÓõÄ×é֯ϸ°û²úÆ·£¬ÔòÊÊÓõÚ351Ìõ£¬Æ¾Ö¤Ò½ÁƺIJľÙÐÐÁÙ´²ÊÔÑé¡£ÑòĤ²úÆ·Ó¦ÓÃÓÚÑÛ±í£¬Ê¹ÓÃÑòĤºÍÑÛÇòĤµÄ¸ß¶ÈÏàËÆÐÔ±¬·¢×÷Óã¬ÊôÓÚͬԴÓÃ;£¬ÎÞÐèÉóÅú¡£¶øÓÃÓÚÉË¿ÚÐÞ¸´¡¢¹Ç¿Æ£¬¸ü¶àʹÓõÄÊÇÑòĤ»îÐÔÒò×Ó¶ø²»ÊÇ×éÖ¯½á¹¹×Ô¼º£¬Òò´Ë²»ÊôÓÚͬԴÓÃ;¡£
FDAµÄÉóÅú¿íÃ⣬µ¼ÖÂÁ˸߶ÈÊèÉ¢µÄÑÛ¿ÆÓÃÑòĤÊг¡£¬FDA¹ÒºÅµÄÑòĤ²úÆ·¸ß´ï930ÖÖ¡£Òò´Ë£¬ÉË¿ÚÐÞ¸´¡¢¹Ç¿Æ³ÉΪMIMEDXµÈÍ·²¿¹«Ë¾Öص㷢Á¦µÄÁìÓò¡£MIMEDX²úÆ·Ö÷ÒªÕë¶ÔÌÇÄò²¡×ãÀ£ÑñµÈÄÑÓúºÏÉË¿ÚÐÞ¸´¡¢ÊÖÊõÉË¿ÚÕչ˻¤Ê¿ÒÔ¼°×ãµ×½îĤÑס¢¸úëìÑ׺ÍÏ¥¹ÇÊàŦÑס£
ÑòĤ²úÆ·ÊôÓÚ×éÖ¯ºÍϸ°û²úÆ·£¬ÍâÑó²úÆ·ÎÞ·¨½øÈëÖйú¡£ÔÚÎÒ¹ú£¬2020Äê²ÅÓеÚÒ»¸ö¿¿½üÐÂÏÊ״̬µÄÑòĤÉÌÆ·»ñÅú¡£´ËÇ°£¬º£ÄÚ½öÓж³¸ÉÑòĤ£¬Òò´ËÑòĤÊÖÊõÒÔÔºÄÚ×ÔÖÆΪÖ÷¡£ÎªÁË°ü¹ÜÊÖÊõЧ¹û£¬²¿·ÖÒ½ÉúʹÓÃ×ÔÖÆÑòĤ£¬ÐèÒªÔÚÔºÄÚ´¦Öóͷ£Ì¥ÅÌ¡£ÓÉÓÚ×ÔÖƲúƷȱ·¦ÊÕ·Ñ·¾¶£¬Ôڼ縺ѬȾΣº¦µÄͬʱ£¬Ò½Éúȱ·¦ÓÐÓü¤Àø£¬ÑòĤÊÖÊõÉø͸ÄÑÌâ¡£
ÑòĤµÄÍƹ㣬ÊÜÏÞÓÚ¶³¸É¹¤ÒÕ¡£Êг¡Ø½ÐèÁ¢ÒìµÄÉÌÆ·ÑòĤ£¬Íê³ÉÁÙ´²¼ÛÖµÓëÉÌÒµ¼ÛÖµµÄͳһ£º
£¨1£©?ʪ̬ÑòĤ£ºÔÚÇå¾²Ìõ¼þÏ£¬×îºéÁ÷ƽ±£´æÑòĤµÄ×éÖ¯½á¹¹¡¢»îÐÔÒò×Ó£¬½«ÊÇÑòĤ´ó¹æÄ£ÍƹãµÄÖ÷ÒªÌõ¼þ¡£ÌØÊâÊÇÔÚÑÛ¿ÆÁìÓò£¬¶³¸ÉÑòĤÓÐÓÃÐÔÓëÐÂÏÊÑòĤ֧¸¶ÄÑÄæ¾³£¬ÐèÒªÁ¢ÒìµÄʪ̬ÑòĤÆƾ֡£
£¨2£©?ÑòĤ¾µ£ºÉúÎïÑòĤÔÚÑÛ²¿µÄÁÙ´²Ó¦ÓÃÒÀÀµÓÚÊÖÊõ·ìºÏ¡£ÎÞ·ìÏßÀο¿Äܹ»ïÔÌÒ½ÉúµÄÉÏÊÖÄѶȡ¢ïÔÌ·ìÏߴ̼¤¡£ÀàËÆÒþÐÎÑÛ¾µµÄÑòĤ¾µ£¬³ÉΪÃâ·ì¿ÉÅå´øµÄÁ¢Òì¼Æ»®¡£³ýÒí×´æÀÈâÍ⣬ÑòĤ¾µ¿ÉÒÔÓ¦ÓÃÓÚ²»¾ÓÉÇå´´/¼¤¹âÖÎÁƽÇĤÇгýÊõµÄ³¡¾°£¬ÔÚÃÅÕïÍê³ÉÕª´÷¡£Ò»¶¨Ë®Æ½ÉÏÒ²»º½âÁËDRGs/DIPË¢ÐÂÏ£¬×¡ÔºÊÖÊõµÄÖ§¸¶Ñ¹Á¦¡£
£¨3£©?΢·ÛÑòĤ£ºMIMEDXÂÊÏÈ̽Ë÷ÁË΢·ÛÐÎʽµÄÑòĤ£¨AmnioFix Injectable£©¡£ÑòĤ΢·Û¾ÐÄÀíÑÎË®ÅäÖÆ¿É×¢ÉäʹÓã¬Ö÷ÒªÕë¶Ô×ãµ×½îĤÑס¢¸úëìÑ׺͹ÇÊàŦÑס£ÏÖÔÚ½îĤÑ×ÈýÆÚÁÙ´²ÒÑÍê³É£¬¸úëìÑ×½øÈëÈýÆÚÁÙ´²£¬¹ÇÊàŦÑ×Ô¤¼Æ½«ÔÚ2022ÄêÆô¶¯ÈýÆÚÁÙ´²¡£
º£ÄÚÉúÎïÑòĤ´ú±í¹«Ë¾
½¨ÉèÓÚ2014ÄêµÄ¹ãÖÝÈðÌ©ÉúÎïÊÇÒ»¼ÒרעÓÚÑۿƺÍÔÙÉúҽѧµÄÁ¢ÒìÆ÷е¹«Ë¾¡£²úÆ·Ïߺ¸ÇÑÛ±í¡¢Çà¹âÑÛ¡¢Çü¹â²»Õý£¬ÍÚ¾òÑۿƸßÖµºÄ²Äʱ»ú£¬Ìî²¹Êг¡¿Õȱ¡£¹«Ë¾ÓµÓк£ÄÚÊ׸ö»ñÅúÉÏÊеÄÉúÎïʪ̬ÑòĤ£¬Ê¹ÓÃÇå¾²¸ßЧµÄ´¦Öóͷ£¹¤ÒÕÅäºÏ¶À¼Ò¿ª·¢µÄÉúÑÄÒº£¬´òÔì³ö»îÐÔ¿¿½üÐÂÏÊÑòĤµÄÉúÎïÑòĤ£¬ÉúÑÄÓÐÓÃÆÚ³¤´ï3Äê¡£¹«Ë¾´ÓÔÙÉúҽѧÇÐÈ룬´òÔìÑÛ¿ÆÁ¢ÒìÆ÷еƽ̨£¬Ö÷Òª²úÆ·»¹°üÀ¨ÑòĤµü´ú²úÆ·ÑòĤ¾µ¡¢¹®Ä¤¾µ¡¢Çà¹âÑÛ΢֧¼ÜµÈ¡£
½Î÷Èð¼ÃÉúÎÐÂÈý°å£º835940£©½¨ÉèÓÚ2002Ä꣬ÊÇÒ»¼Òפ×ãÓÚÔÙÉúҽѧ¼°ÉúÃü¿µ½¡¹¤Òµ£¬¼¯Éú²ú¡¢Ñз¢¡¢ÏúÊÛΪһÌåµÄ¹ú¼Ò¸ßÐÂÊÖÒÕÆóÒµ¡£Ö÷Òª²úÆ·°üÀ¨Ñۿƶ³¸ÉÑòĤ¡¢¹Ç¿Æ¶³¸ÉÑòĤ¡¢ÑòĤÀáµÀÐÞ¸´Ö§¼ÜµÈ¡£Èð¼ÃÉúÎïÒÔÈËÑòĤΪÒÀÍУ¬Ê¹ÓÃ×ÔÉíÇ¿Ê¢µÄÑз¢ÍŶӣ¬ÍŽảÄÚ×ÅÃû´óѧ¡¢Ñо¿Ëù¼°Ò½ÔºÏàÖúÍê³ÉÑòĤϵÁвúÆ·µÄÉú²úºÍÑз¢¡£
¹ãÖÝÔÃÇåÔÙÉúҽѧ¿Æ¼¼ÓÐÏÞ¹«Ë¾½¨ÉèÓÚ2015Ä꣬ÊÇÒ»¼Òפ×ãÓÚÑÛ¿ÆÔÙÉúҽѧ£¬ÒÔ½¹µãרÀûÊÖÒÕΪ»ùʯ£¬×¨Òµ´ÓÊÂÑÛ±íÖÎÁƼ°ÐÞ¸´¡¢ÊÓ¹âµ÷½â¡¢¸ÉÑÛµ÷ÀíµÈÖÖÖÖÑÛ¿ÆÒ½ÁÆÆ÷еÑз¢¡¢Éú²ú¼°ÏúÊÛΪһÌåµÄ¸ß¿Æ¼¼ÆóÒµ¡£²úÆ·°üÀ¨ÉúÎï½ÇĤ¡¢ÉúÎïÑòĤ¼°ÑÛ¿ÆÊÖÊõÆ÷е¡£
×ÊÁÏȪԴ£º
1. ĤÉúÎïÖÊÁϼ°ÔÚ×éÖ¯¹¤³ÌÖеÄÓ¦Ó㺡°Ö¸µ¼Ä¤ÔÙÐÄÀíÂÛ¡±µÄÕ¹Íû
2.?Update review on five top clinical applications of human amniotic membrane in regenerative medicine
3.?Transforming ocular surface stem cell research into successful clinical practice
4. ÑòĤÔÚÑÛ¿ÆÁÙ´²ÊÂÇéÖеÄÓ¦ÓÃÏ£Íû
5.?Plastic Repair of Conjunctival Defects with Fetal Membranes
6. Comment on ¡°Cornea Classic Article: Kim JC and Tseng SCG: Transplantation of Preserved Amniotic Membrane for Surface Reconstruction in Severely Damaged Rabbit Corneas¡±
7.?Amniotic Membrane Grafts to Reduce Pterygium Recurrence
8.?Device©\modified trabeculectomy for glaucoma
9.?Õ׿ÆÑÛ¿ÆÕйÉÊé
10.?Recurrent Pterygium: A Review
11.?ÈËÑòĤÔڹǿÆÁìÓòµÄÑо¿Ï£Íû
12.?Applications of the amniotic membrane in tissue engineering and regeneration: the hundred-year challenge
13.?Human Amniotic Membrane: A review on tissue engineering, application, and storage
14. Amniotic membrane in ophthalmology: properties, preparation, storage and indications for grafting¡ªa review
15.??HUMAN CELL AND TISSUE ESTABLISHMENT REGISTRATION
16. Amniotic Membrane and Amniotic Fluid Injections for Non Ophthalmic Applications – CAM 701149
17.? Èð¼ÃÉúÎï¹ÙÍø
18.? ÈðÌ©ÉúÎï¹ÙÍø